Influence of eicosanoids on renal function of DOCA-salt hypertensive rats

R. J. Roman, M. L. Kaldunski, D. L. Mattson, M. Mistry, A. Nasjletti

Research output: Contribution to journalArticle

Abstract

The present study examined the contribution of changes in the synthesis or degradation (or both) of renal eicosanoids to the alterations in renal hemodynamics observed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Renal blood flow and glomerular filtration rate were markedly reduced in DOCA-salt hypertensive rats compared with values observed in controls rats given water or saline to drink. The abnormalities in renal hemodynamics in the hypertensive rats were associated with an increase in the excretion of thromboxane B2, an increase in the release of thromboxane B2 from renal cortical tissue slices, and a diminished release of prostaglandin E2 (PGE2) from renal medullary tissue. Additionally, the urinary excretion of PGE2 and 6-keto-prostaglandin F(1α) (6-keto-PGF(1α)) and the release of 6-keto-PGF(1α) from renal cortical and medullary tissue were elevated in rats with DOCA-salt hypertension. Since the excretion of PFE2 and 6-keto-PGF(1α) and the release of 6-keto-PGF(1α) by medullary tissue were also elevated in normotensive rats given 1% NaCl solution to drink, these latter changes probably were related to an elevation of sodium intake rather than to the development of hypertension. The functional significance of the alterations in the renal production of thromboxane in DOCA-salt hypertensive rats was evaluated by comparing the effects of a thromboxane synthesis inhibitor and a receptor antagonist on renal function in normotensive and DOCA-salt hypertensive rats. The administration of the thromboxabe synthetase inhibitor furegrelate and the thromboxane receptor blocker SQ 29548 had no effect on renal hemodynamics in either group. These results suggest that the elevated renal production of thromboxane A2 is not responsible for the reduction of renal blood flow and glomerular filtration rate in rats with established DOCA-salt hypertension.

Original languageEnglish (US)
Pages (from-to)287-294
Number of pages8
JournalHypertension
Volume12
Issue number3
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Desoxycorticosterone
Eicosanoids
Acetates
Salts
Kidney
Prostaglandins F
Thromboxane B2
Renal Circulation
Hemodynamics
Thromboxanes
Hypertension
Glomerular Filtration Rate
Dinoprostone
Thromboxane Receptors
Thromboxane A2
Ligases
Sodium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Roman, R. J., Kaldunski, M. L., Mattson, D. L., Mistry, M., & Nasjletti, A. (1988). Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. Hypertension, 12(3), 287-294. https://doi.org/10.1161/01.HYP.12.3.287

Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. / Roman, R. J.; Kaldunski, M. L.; Mattson, D. L.; Mistry, M.; Nasjletti, A.

In: Hypertension, Vol. 12, No. 3, 01.01.1988, p. 287-294.

Research output: Contribution to journalArticle

Roman, RJ, Kaldunski, ML, Mattson, DL, Mistry, M & Nasjletti, A 1988, 'Influence of eicosanoids on renal function of DOCA-salt hypertensive rats', Hypertension, vol. 12, no. 3, pp. 287-294. https://doi.org/10.1161/01.HYP.12.3.287
Roman RJ, Kaldunski ML, Mattson DL, Mistry M, Nasjletti A. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. Hypertension. 1988 Jan 1;12(3):287-294. https://doi.org/10.1161/01.HYP.12.3.287
Roman, R. J. ; Kaldunski, M. L. ; Mattson, D. L. ; Mistry, M. ; Nasjletti, A. / Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. In: Hypertension. 1988 ; Vol. 12, No. 3. pp. 287-294.
@article{a223dcd64e5d451fb82780c9ca009248,
title = "Influence of eicosanoids on renal function of DOCA-salt hypertensive rats",
abstract = "The present study examined the contribution of changes in the synthesis or degradation (or both) of renal eicosanoids to the alterations in renal hemodynamics observed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Renal blood flow and glomerular filtration rate were markedly reduced in DOCA-salt hypertensive rats compared with values observed in controls rats given water or saline to drink. The abnormalities in renal hemodynamics in the hypertensive rats were associated with an increase in the excretion of thromboxane B2, an increase in the release of thromboxane B2 from renal cortical tissue slices, and a diminished release of prostaglandin E2 (PGE2) from renal medullary tissue. Additionally, the urinary excretion of PGE2 and 6-keto-prostaglandin F(1α) (6-keto-PGF(1α)) and the release of 6-keto-PGF(1α) from renal cortical and medullary tissue were elevated in rats with DOCA-salt hypertension. Since the excretion of PFE2 and 6-keto-PGF(1α) and the release of 6-keto-PGF(1α) by medullary tissue were also elevated in normotensive rats given 1{\%} NaCl solution to drink, these latter changes probably were related to an elevation of sodium intake rather than to the development of hypertension. The functional significance of the alterations in the renal production of thromboxane in DOCA-salt hypertensive rats was evaluated by comparing the effects of a thromboxane synthesis inhibitor and a receptor antagonist on renal function in normotensive and DOCA-salt hypertensive rats. The administration of the thromboxabe synthetase inhibitor furegrelate and the thromboxane receptor blocker SQ 29548 had no effect on renal hemodynamics in either group. These results suggest that the elevated renal production of thromboxane A2 is not responsible for the reduction of renal blood flow and glomerular filtration rate in rats with established DOCA-salt hypertension.",
author = "Roman, {R. J.} and Kaldunski, {M. L.} and Mattson, {D. L.} and M. Mistry and A. Nasjletti",
year = "1988",
month = "1",
day = "1",
doi = "10.1161/01.HYP.12.3.287",
language = "English (US)",
volume = "12",
pages = "287--294",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Influence of eicosanoids on renal function of DOCA-salt hypertensive rats

AU - Roman, R. J.

AU - Kaldunski, M. L.

AU - Mattson, D. L.

AU - Mistry, M.

AU - Nasjletti, A.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The present study examined the contribution of changes in the synthesis or degradation (or both) of renal eicosanoids to the alterations in renal hemodynamics observed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Renal blood flow and glomerular filtration rate were markedly reduced in DOCA-salt hypertensive rats compared with values observed in controls rats given water or saline to drink. The abnormalities in renal hemodynamics in the hypertensive rats were associated with an increase in the excretion of thromboxane B2, an increase in the release of thromboxane B2 from renal cortical tissue slices, and a diminished release of prostaglandin E2 (PGE2) from renal medullary tissue. Additionally, the urinary excretion of PGE2 and 6-keto-prostaglandin F(1α) (6-keto-PGF(1α)) and the release of 6-keto-PGF(1α) from renal cortical and medullary tissue were elevated in rats with DOCA-salt hypertension. Since the excretion of PFE2 and 6-keto-PGF(1α) and the release of 6-keto-PGF(1α) by medullary tissue were also elevated in normotensive rats given 1% NaCl solution to drink, these latter changes probably were related to an elevation of sodium intake rather than to the development of hypertension. The functional significance of the alterations in the renal production of thromboxane in DOCA-salt hypertensive rats was evaluated by comparing the effects of a thromboxane synthesis inhibitor and a receptor antagonist on renal function in normotensive and DOCA-salt hypertensive rats. The administration of the thromboxabe synthetase inhibitor furegrelate and the thromboxane receptor blocker SQ 29548 had no effect on renal hemodynamics in either group. These results suggest that the elevated renal production of thromboxane A2 is not responsible for the reduction of renal blood flow and glomerular filtration rate in rats with established DOCA-salt hypertension.

AB - The present study examined the contribution of changes in the synthesis or degradation (or both) of renal eicosanoids to the alterations in renal hemodynamics observed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Renal blood flow and glomerular filtration rate were markedly reduced in DOCA-salt hypertensive rats compared with values observed in controls rats given water or saline to drink. The abnormalities in renal hemodynamics in the hypertensive rats were associated with an increase in the excretion of thromboxane B2, an increase in the release of thromboxane B2 from renal cortical tissue slices, and a diminished release of prostaglandin E2 (PGE2) from renal medullary tissue. Additionally, the urinary excretion of PGE2 and 6-keto-prostaglandin F(1α) (6-keto-PGF(1α)) and the release of 6-keto-PGF(1α) from renal cortical and medullary tissue were elevated in rats with DOCA-salt hypertension. Since the excretion of PFE2 and 6-keto-PGF(1α) and the release of 6-keto-PGF(1α) by medullary tissue were also elevated in normotensive rats given 1% NaCl solution to drink, these latter changes probably were related to an elevation of sodium intake rather than to the development of hypertension. The functional significance of the alterations in the renal production of thromboxane in DOCA-salt hypertensive rats was evaluated by comparing the effects of a thromboxane synthesis inhibitor and a receptor antagonist on renal function in normotensive and DOCA-salt hypertensive rats. The administration of the thromboxabe synthetase inhibitor furegrelate and the thromboxane receptor blocker SQ 29548 had no effect on renal hemodynamics in either group. These results suggest that the elevated renal production of thromboxane A2 is not responsible for the reduction of renal blood flow and glomerular filtration rate in rats with established DOCA-salt hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0023721931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023721931&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.12.3.287

DO - 10.1161/01.HYP.12.3.287

M3 - Article

C2 - 3169943

AN - SCOPUS:0023721931

VL - 12

SP - 287

EP - 294

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -